Daily non-political popular news in brief.

Epstein-Barr: a virtual look at a vexing virus

Researchers have created a computer model called Pathogen Simulation to study the sometimes deadly Epstein-Barr virus, which infects greater than 90 percent of the world's population. By using PathSim to study EBV, researchers hope to determine why some infected patients fall ill while others show no symptoms.

Read more »

Keywords: epstein-barr, virtual, look, vexing, virus, epstein, barr, viru

« Previous | Next »

Similar news on "Epstein-Barr: a virtual look at a vexing virus":

1. Three-in-one virus killer prevents common, often fatal infections
   10-26-2006 · EurekAlert!
   A novel combination therapy drastically reduces the infection rate of three prevalent viruses -- and risk of death -- in transplant patients with compromised immune systems. Trivirus-specific cytotoxic T lymphocytes (CTLs), the first multivirus killer of its kind, called, controlled infections caused by three commonplace viruses -- cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus -- with no toxicity in a phase 1 trial.
   Similar news · Read more »
   
2. Malaria and Epstein-Barr virus linked to pediatric cancer in Africa
   06-07-2007 · EurekAlert!
   Arnaud Chene and colleagues have identified CIDRla as the first microbial protein able to spur a latently EBV-infected cell into active production. Their results suggest that P. falciparum-derived proteins can lead to a direct reactivation of EBV during acute malaria infection, increasing the risk of Burkitt lymphoma development for children living in malaria-endemic areas.
   Similar news · Read more »
   
3. Vaccine shows promise in preventing mono
   12-10-2007 · EurekAlert!
   A new study suggests that a vaccine targeting Epstein-Barr virus may prevent infectious mononucleosis, commonly known as "mono" or "glandular fever." The study is published in the Dec. 15 issue of the Journal of Infectious Diseases, now available online.
   Similar news · Read more »
   
4. Unique role of cell death protein TRADD in viral signaling
   01-14-2008 · EurekAlert!
   A unique Epstein Barr virus-derived protein interaction domain uses the cellular death domain protein TRADD to assemble its transforming signaling complex and dictates a transferable nonapoptitic phenotype of TRADD signaling.
   Similar news · Read more »
   
5. A tricky tumor virus
   01-17-2008 · EurekAlert!
   Viruses use many tricks to gain control over their host cells and to reprogram them to their own advantage. Dr. Arnd Kieser and his colleagues of the Department of Gene Vectors of the Helmholtz Zentrum Munich, Germany, were able to show in a recent publication in PLoS Biology by which mechanism Epstein-Barr virus exploits a signal protein of its host cell, which normally mediates programmed cell death, in order to convert the cell into a cancer cell.
   Similar news · Read more »
   
6. Researchers wake up viruses inside tumors to image and then destroy cancers
   03-01-2007 · EurekAlert!
   Researchers have found a way to activate Epstein-Barr viruses inside tumors as a way to identify patients whose infection can then be manipulated to destroy their tumors. They say this strategy could offer a novel way of treating many cancers associated with Epstein-Barr, including at least four different types of lymphoma and nasopharyngeal and gastric cancers.
   Similar news · Read more »
   
7. Virtual human in HIV drug simulation
   01-29-2008 · EurekAlert!
   The combined supercomputing power of the UK and US 'national grids' has enabled UCL scientists to simulate the efficacy of an HIV drug in blocking a key protein used by the lethal virus. The method -- an early example of the Virtual Physiological Human in action -- could one day be used to tailor personal drug treatments, for example for HIV patients developing resistance to their drugs.
   Similar news · Read more »
   
8. An inverse way for engineering
   10-31-2007 · EurekAlert!
   In general, thinking in engineering is carried out conceptually, the concepts being processed in the computer virtually and, in the end, the object or the part is obtained. In the case of inverse engineering, however, the path to be followed is exactly the reverse: the object or the part that physically exists ends up transformed into something virtual. This is exactly what they do in the Product Design Laboratory at the Higher School of Engineering in Bilbao.
   Similar news · Read more »
   
9. Effective Preventive Drug Against Bird Flu Developed In The Mouse
   10-13-2006 · ScienceDaily
   Researchers have developed what could be used as an effective preventive drug against bird flu. In a study published today in the open access journal Respiratory Research, researchers have created antibodies against the avian flu virus H5N1 that work in mice both as a preventive drug, or prophylaxis, when administered before infection, and as a treatment for bird flu.
   Similar news · Read more »
   
10. Patients who recover from hepatitis C have lower risk of reinfection
    11-01-2006 · EurekAlert!
    A new study found that individuals who had tested positive for hepatitis C (HCV) but later tested negative for the virus were significantly less likely to become infected again compared to those who had never been infected, even though they had the same exposure risks.
    Similar news · Read more »